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Background. Macrophages and synovial fibroblasts (SF) are two major cells implicated in the pathogenesis of rheumatoid arthritis
(RA). SF could be a source of cytokines and growth factors driving macrophages survival and activation. Here, we studied the
effect of SF on monocyte viability and phenotype. Methods. SF were isolated from synovial tissue of RA patients and CD14+ cells
were isolated from peripheral blood of healthy donors. SF conditioned media were collected after 24 hours of culture with or
without stimulation with TNF𝛼 or IL-1𝛽. Macrophages polarisation was studied by flow cytometry. Results. Conditioned medium
from SF significantly increased monocytes viability by 60% compared to CD14+ cells cultured in medium alone (𝑃 < 0.001). This
effect was enhanced using conditioned media from IL-1𝛽 and TNF𝛼 stimulated SF. GM-CSF but not M-CSF nor IL34 blocking
antibodies was able to significantly decrease monocyte viability by 30% when added to the conditioned media from IL-1𝛽 and
TNF𝛼 stimulated SF (𝑃 < 0.001). Finally, monocyte cultured in presence of SF conditioned media did not exhibit a specific M1
or M2 phenotype. Conclusion. Overall, rheumatoid arthritis synovial fibroblasts stimulated with proinflammatory cytokines (IL-1𝛽
and TNF𝛼) promote monocyte viability via GM-CSF but do not induce a specific macrophage polarization.
1. Introduction
Rheumatoid arthritis is an autoimmune disease characterized
by a chronic inflammation of the synovial membrane that
leads to joint destruction. The inflammatory and resident
cells present in the synovial tissue play a major role in the
pathogenesis of the disease through the production of a
wide range of proinflammatory cytokines and growth factors.
Synovial fibroblasts (SF) and macrophages are two cell types
composing the lining layer of the normal synovial tissue.They
are also the main cells found in the inflamed synovium of
RA patients. In RA, SF acquire a pseudotumoral phenotype
characterized by a higher proliferation rate, invasiveness,
and a resistance to apoptosis leading to hypertrophy of the
lining layer [1, 2]. These cells play a key role by producing
cytokines (IL-6 and receptor activator for nuclear factor 𝜅 B
ligand (RANKL)) that perpetuate inflammation and induce
bone destruction and metalloproteases that contribute to
cartilage damage. Besides their contribution to cartilage
and bone damage, SF seem to play a crucial role in the
homing, growth, or function of other cell types, such as
inflammatory cells [3]. For instance, SF are a source of
chemokines and also of hematopoietic growth factors such
asmonocyte chemoattractant protein 1 (MCP-1),macrophage
colony stimulating factor (M-CSF), IL-34, or granulocyte-
macrophage colony-stimulating factor (GM-CSF) that can
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support monocyte migration and macrophage activation in
the synovium.
Macrophages are also among the major cells involved in
the pathogenesis of inflammatory arthritis. These cells are
abundant in the inflamed synovial tissue and their number in
the synovial sublining layer is correlated with disease activity
and response to treatment [4, 5]. Their importance is also
underlined by the efficacy of therapies targetingmacrophage-
derived cytokines (TNF𝛼 or IL-1𝛽) in RA [6]. These cells can
be derived from circulatingmonocytes which are recruited in
the synovial tissue or from the differentiation of macrophage
precursors already present in the joint. It has been shown that
the main factors of monocytes/macrophages survival such
as M-CSF, IL-34, or GM-CSF are expressed in the synovial
fluid and membrane of RA patients [7–9]. The involvement
of these factors in the inflammation and destruction of
the joint has been demonstrated in animal models of RA.
Thus, op/op mice lacking functional M-CSF are protected
against antigen induced arthritis [10]. Furthermore, GM-CSF
has been shown to exacerbate arthritic disease in animals,
whilst GM-CSF deficient mice are protected from collagen-
induced arthritis [11, 12]. These studies demonstrate that M-
CSF and GM-CSF can exacerbate the inflammatory response
and support the role of monocytes/macrophages in the
pathogenesis of inflammatory arthritis.
It is increasingly clear that macrophages are a heteroge-
neous population and that they should be classified according
to their phenotype and function [13]. Macrophages can be
subdivided in two groups: classically activated macrophages
(M1) which are proinflammatory via the secretion of
cytokines such as TNF𝛼, IL-1𝛽, and IL-12 and alternatively
activated macrophages (M2) which have anti-inflammatory
functions (secretion of IL-10, IL-1RA, and transforming
growth factor-𝛽) and promote tissue repair [14]. The pheno-
type of synovial macrophages is heterogeneous as suggested
by the concomitant expression of markers M1 and M2 [15].
The macrophage polarization may vary depending on the
disease activity or the treatment such as glucocorticoids
that are known to promote M2 polarization [16]. It has
also been hypothesized that an imbalance between pro- and
anti-inflammatory macrophages could be involved in the
chronicity of inflammation.
SF andmacrophages are in close contact in the synovium.
As the SF are sources of cytokines and growth factors, it has
been hypothesized that these cells may regulate the survival
and activation of monocytes/macrophages in the synovial
tissue. However, it is not known what factors (M-CSF, IL-34,
orGM-CSF) are involved in the promotion ofmonocytes sur-
vival in the rheumatoid synovium.This question is important
because new therapeutic strategies targetingM-CSF andGM-
CSF are in development. Moreover, it is unclear whether SF
are able to influence macrophage polarization. In this work,
we have shown that RA SF can promote monocyte viability
through the secretion of GM-CSF and not of M-CSF or IL-
34. IL-1𝛽 was the main cytokine inducing the production of
GM-CSF by SF. Finally, SF could not induce specific M1 or
M2 phenotype.
2. Materials and Methods
2.1. Human Samples. All patients enrolled have given their
formal consent. The study was approved by the local ethics
committee and by the French Research Ministry (N∘2008-
402) in accordance with the Declaration of Helsinki.
2.1.1. CD14+ Monocytes Isolation. Blood samples were
obtained from the “Etablissement Franc¸ais du Sang”. For
CD14+ monocytes, peripheral blood mononuclear cells from
10 different donors were isolated by centrifugation over
Ficoll gradient (Sigma-Aldrich, USA). CD14+ cells were
magnetically labeled with CD14 microbeads and positively
selected by MACS technology (Miltenyi Biotec, Germany).
CD14+ cells were CD3− by flow cytometry (purity ≥ 95%)
and were frozen prior to further experiments.
2.1.2. Synovial Fibroblasts and Synovial Fluids. Synovial biop-
sies were obtained surgically at the time of joint replacement
surgery or joint synovectomy from rheumatoid arthritis
patients. Overall, biopsies from 9 different patients were
used for our experiments. SF were obtained from synovial
tissue after incubation in collagenase A (1mg/mL) (Sigma-
Aldrich) for 2 hours. After filtrationwith a 70 𝜇mcell strainer,
cells were cultured in RPMI 1640 medium (Lonza, Belgium)
supplemented with 10% of fetal bovine serum (ThermoSci-
entific, USA) and 1% of antibiotics (penicillin/Streptomycin
(Lonza)). Nonadherent cells were removed by washing with
Dulbecco’s phosphate buffered saline (DPBS) (Lonza) at 24 h.
Analysis by flow cytometry showed expression of CD90 by
more than 90% of the isolated cells. Cells were used between
passage 3 and 8.
Synovial fluids were obtained from the Rheumatology
Department of the Nantes University Hospital. Cells were
removed by centrifugation (3600 rpm, 15 minutes) and fluids
were stored immediately at−80∘C. Synovial fluidswere obtain
from 14 osteoarthritis (OA) and 31 RA patients during a flare
of the disease. Patients were suffering fromRA for 188months
(± 140). Rheumatoid factor and anti-CCP antibodies were
positive in 71% and 76% of patients, respectively, and 62% of
patients were positive for both. Sixty-seven percent of these
patients had bone erosions.
2.2. Synovial Fibroblasts Conditioned Media. SF conditioned
media were generated from RA SF or cultured in RPMI with
2% of FBS for 12 hours and treated or not (CT) with 25 ng/mL
of TNF𝛼 or IL-1𝛽 (R&D Systems) for 24 hours. At the end
of the stimulation, the conditioned media were centrifugated
(5 minutes, 1600 rpm) to remove cells and debris, aliquoted,
and stored at −80∘C after that. Conditioned media from OA
patients were also generated without stimulation by cytokine.
2.3. RNA Isolation and Real-Time PCR. RA SF total RNA
was extracted using Trizol reagent (Invitrogen, France). First-
strand cDNA was synthesized from 1𝜇g total RNA using the
Maxima HMinus First Strand cDNA Synthesis Kit (Thermo-
Scientific). Real-time PCR was performed using SYBRGreen
Supermix (Bio-Rad, France). Quantitative PCRs (qPCRs)
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were carried out on a CFX96 Real-Time PCR Detection
System (Bio-Rad). Analyses were performed using human
hypoxanthine-guanine phosphoribosyltransferase (HPRT) as
invariant control.
2.4.WST-1 Viability Assay. After thawing, CD14+monocytes
were counted and resuspended in 𝛼MEM medium supple-
mented with 20% FBS. In a 96-well plate, we added 50 𝜇L of
cells in each well (45,000 cells/well) and then 50 𝜇L ofM-CSF,
IL-34, and GM-CSF (all from R&D systems) diluted in 2%
RPMI to obtain a 25, 50, and 10 ng/mL final concentration,
respectively, or 50 𝜇L of RA SF conditioned media. Medium
(50𝜇L; 2% FBS) without any cytokine was used as control
condition (CT). After 3 days, cell viability was assessed by
WST-1 cell proliferation Reagent (Roche, France) by adding
10 𝜇L per well. The formazan dye obtained from WST-1
cleavage by mitochondrial dehydrogenase was read by a
microplate reader Wallac 1420 Victor 2 (Perkin Elmer, USA)
between 420 and 480 nm after incubation for 4 hours at 37∘C.
Antibodies used to identify cytokines implicated inmonocyte
viability were as follows: antiM-CSF (R&D Systems), anti-IL-
34 (Diaclone, INSERM UMR957), and anti-GM-CSF (R&D
Systems) at 2, 10, and 5𝜇g/mL, respectively. We have previ-
ously tested different antibody concentrations to determine
the most appropriate concentrations.
2.5. Quantification of Cytokine Levels in Synovial Fluids and
ConditionedMedia. GM-CSF levels were measured in RA SF
conditionedmedia by ELISA assay (HumanGM-CSFDuoSet
ELISA development kit, R&D Systems). In synovial fluids,
GM-CSF, IL-1𝛽, and TNF𝛼 levels were measured using the
Luminex technology (Bio-Plex ProAssays fromBio-Rad) and
M-CSF levels using ELISA Assay (Human M-CSF Duoset,
R&D Systems).
2.6. Flow Cytometry. To determine the phenotype of differ-
entiated cells obtained in the presence of RA SF conditioned
media, we used flow cytometry. CD14+ monocytes were cul-
tured 4 days in 𝛼MEM supplemented with 10% FBS alone or
with IFN𝛾 (50 ng/mL; M1) or IL-4 (50 ng/mL; M2a) or IL-10
(50 ng/mL; M2c) or RA SF conditioned media diluted at 1/2.
The cells were collected using StemPro Accutase (Life Tech-
nologies) washed with DPBS and incubated for 1 hour with
the following antibodies: anti-CD14/Brilliant Violet 605, anti-
CD16/Brilliant Violet 421, anti-CD64/Alexa Fluor 488, anti-
CD163/Alexa Fluor 647, and anti-CD200R/Phycoerythrine
(PE) (all from BioLegend, USA). Cells were analyzed with
a BD LSR II flow cytometer (BD Biosciences) using BD
FACSDiva Software (BDBiosciences). Values are expressed as
the ratio of mean fluorescence intensity (MFI) of the marker
on stimulated cells over MFI of unstimulated cells (CD14+
monocytes cultured 4 days in 𝛼MEMsupplementedwith 10%
FBS only).
2.7. Statistics. We used a Kruskall-Wallis test for multigroup
comparison. Mann-Whitney test was then used to compare
each group. Correlation between cytokines concentration in
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Figure 1: SF conditioned media promote monocyte viability. CD14+
cells were cultured 3 days in presence of medium alone (control
(CT) cells), M-CSF, IL-34, GM-CSF, or conditioned media from RA
SF stimulated or not (NS) with TNF𝛼 or IL-1𝛽 for 24 hours and
from not stimulated OA SF. Monocyte viability was evaluated by
colorimetric assay (WST-1). Results are given as the percentage of
viability induced by M-CSF (100%) (𝑛 = 9 patients for RA and 2
patients for OA). ∗𝑃 < 0.05; ∗∗𝑃 < 0.001; ∗∗∗𝑃 < 0.0001.
synovial fluids was studied using the nonparametric Spear-
man rank order test. 𝑃 < 0.05 was considered statistically
significant.
3. Results
3.1. Synovial Conditioned Media Increase Monocyte Viability.
First, we investigated whether soluble factors produced by
SF could promote monocyte viability. CD14+ cells isolated
from healthy donors were cultured for 3 days in presence of
conditioned media from RA SF. Cell viability in each con-
dition of conditioned media was evaluated by colorimetric
assay (WST-1) and compared to the viability induced by M-
CSF, IL-34, or GM-CSF. Results are expressed in percentage
of viability induced by M-CSF (100%). As shown in Figure 1,
monocyte viability was significantly increased by conditioned
media compared to control cells. This effect was equivalent
to that observed with M-CSF, GM-CSF, or IL-34 when using
conditioned medium from nonstimulated SF. In contrast,
this effect was stronger when using conditioned media from
SF prestimulated 24 hours with IL-1𝛽 or TNF𝛼. In these
conditions, monocyte viability was significantly increased
compared to M-CSF alone (+29% (𝑃 = 0.05) and +52%
(𝑃 = 0.004) for TNF𝛼 and IL-1𝛽 conditioned media, resp.).
OA SF conditioned medium induced a significant increase in
monocyte viability compared to CD14 alone (𝑃 < 0.001) but
this effect was weaker than the one induced by M-CSF or RA
SF conditioned media (𝑛 = 2).
3.2. Synovial Fibroblasts Express the Main Monocyte Survival
Factors M-CSF, IL-34, and GM-CSF and This Expression Is
Increased by TNF𝛼 or IL-1𝛽 Stimulation. As SF conditioned
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Figure 2: Effect of IL-1𝛽 and TNF𝛼 on M-CSF, IL-34, and GM-CSF expression in RA SF. SF were stimulated by IL-1𝛽 (25 ng/mL) or TNF𝛼
(25 ng/mL) for 24 hours. (a)–(c) RNA was harvested and a qPCR for M-CSF, IL-34, and GM-CSF expression was performed. Results are
given as the relative expression using hHPRT gene as housekeeping gene.The bars represent the mean and each plots one biological replicate
(𝑛 = 6 patients). (d) GM-CSF concentration (pg/mL) was assessed by ELISA. Results are given as the mean (± SEM). ∗𝑃 < 0.05; ∗∗𝑃 < 0.001;
∗∗∗
𝑃 < 0.0001.
media were able to promote monocyte survival, we then
studied the expression of the main monocyte survival factors
by SF (M-CSF, IL-34, and GM-CSF) and their regulation
by the proinflammatory cytokines IL-1𝛽 and TNF𝛼. After
24 hours of culture with or without TNF𝛼 (25 ng/mL) or
IL-1𝛽 (25 ng/mL), synoviocytes RNA was harvested and
gene expression studied by qPCR. As shown in Figure 2,
unstimulated SF expressed M-CSF and IL-34 whereas GM-
CSF was weakly expressed, with no expression in some SF.
TNF𝛼 stimulation significantly increased M-CSF, IL-34, and
GM-CSF expression by SF. In contrast, IL-1𝛽 stimulation
had no significant effect on M-CSF and IL-34 expression
but was able to increase GM-CSF expression by 450 (±233)-
fold, compared to unstimulated cells. We confirmed these
results at the protein level by ELISA assay: IL-1𝛽 stimulation
significantly increased GM-CSF concentration (285 pg/mL
(±141)) compared to TNF𝛼 stimulation (45 pg/mL (±30)) and
to unstimulated cells (7 pg/mL (±3) (𝑃 = 0.03 and𝑃 = 0.0006
for TNF𝛼 and IL-1𝛽, resp.)).
3.3. Anti-GM-CSF Antibodies but Not M-CSF or IL-34 Anti-
bodies Inhibit the Monocyte Viability Induced by Conditioned
Media from SF Prestimulated with IL-1𝛽 and TNF𝛼. We
then wanted to identify which factors of M-CSF, IL-34, or
GM-CSF were involved in maintaining monocyte viability
in SF conditioned media. Freshly isolated CD14+ cells were
cultured 3 days with SF conditioned media in the presence
of M-CSF, IL-34, or GM-CSF blocking antibodies. As shown
in Figure 3, no antibody was able to inhibit the effect of
unstimulated SF conditioned media. Only GM-CSF blocking
antibodies inhibited 30% of the effect of conditioned media
from IL-1𝛽 or TNF𝛼 prestimulated SF. In addition, blocking
antibodies targeting the IL-6 family (anti-gp130 and anti-IL-
6) had no biological effect (data not shown).Thus, GM-CSF is
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Figure 3: Neutralisation of GM-CSF but not M-CSF nor IL-34 reduces monocyte viability induced by IL-1𝛽 and TNF𝛼 prestimulated SF
conditionedmedia. CD14+ cells were cultured 3 days in presence ofM-CSF (25 ng/mL), IL-34 (50 ng/mL),GM-CSF (10 ng/mL), or conditioned
media from SF prestimulated or not (NS) with TNF𝛼 or IL-1𝛽 for 24 hours. Blocking antibodies against M-CSF, IL-34, and GM-CSF, at 2, 10,
and 5𝜇g/mL, respectively, were added at the same time. Results are given as the mean percentage of viability (± SEM) considering M-CSF as
control (100%) (𝑛 = 3–5 patients). ∗𝑃 < 0.05; ∗∗𝑃 < 0.001; ∗∗∗𝑃 < 0.0001.
one of the cytokines involved in the effect of SF on monocyte
survival but only after cell stimulation by proinflammatory
cytokines.
3.4. Macrophages Induced by Synovial Fibroblasts Conditioned
Media Do Not Exhibit a Specific Phenotype. Macrophages
can be subdivided in 2 specific groups: classically activated
macrophages (M1) that are proinflammatory and alterna-
tively activated macrophages (M2) which have an anti-
inflammatory and tissue repair function. To determine the
phenotype ofmacrophages induced by SF conditionedmedia,
we performed a FACS analysis of the cell surface mark-
ers for classical (CD14), nonclassical (CD16), M1 (CD64),
M2a (CD200R), and M2c (CD163) macrophages (Figure 4).
Results are expressed as the ratio of the mean fluorescence
intensity (MFI) of the marker over the MFI of unstimulated
cells. As expected, stimulation with INF-gamma, IL-4, and
IL-10 increased CD64 (18.3 ± 3.4-fold), CD200R (5.6 ± 2.9-
fold), and CD163 (5 ± 2.4-fold) expression, respectively. In
contrast, we did not find any regulation of the cell surface
markers on the cells differentiated with unstimulated SF
conditioned media. A slight but not significant increase in
CD14 was observed in monocytes cultured with TNF𝛼 and
IL-1𝛽 stimulated SF conditioned media and in CD163 in
those cultured with IL-1𝛽 stimulated SF conditioned media.
Overall, our data show that although SF conditioned media
increase monocyte viability and proliferation, they cannot
induce M1 or M2 macrophages markers.
3.5. GM-CSF Concentration Is Increased in Synovial Fluids
from RA Patients and Is Correlated with TNF𝛼 and IL-1𝛽
Concentrations. Cytokines present in the synovial microen-
vironment are also found in the synovial fluid of patients with
inflammatory arthritis. We have already shown that IL-34
was elevated in RA synovial fluids compared to osteoarthritis
(OA) [7]. Thus, we next assessed concentrations of M-
CSF, GM-CSF, IL-1𝛽, and TNF𝛼 in the synovial fluids
(Figure 5). We found a significant increase in the levels
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Figure 4: SF conditioned media do not regulate the expression of typical M1 or M2 surface markers. CD14+ monocytes were cultured 4 days in
presence of medium with 10% FBS without (not stimulated cells) or with IFN𝛾 (50 ng/mL; M1) or IL-4 (50 ng/mL; M2a) or IL-10 (50 ng/mL;
M2c) or RA SF conditioned media. FACS analysis of the cell surface markers for classical (CD14), nonclassical (CD16), M1 (CD64), M2a
(CD200R), and M2c (CD163) macrophages was thus performed. Values are expressed as the ratio of the mean fluorescence intensity (MFI)
of the marker on the stimulated cells over MFI of unstimulated cells. Bars represent the mean (± SEM) of 3 independent experiments.
of all these cytokines in RA compared to OA. Mean M-
CSF concentrations were 5.2 pg/mL (±0.75) and 12 pg/mL
(±2.7) (𝑃 = 0.0067) whereas GM-CSF mean concentra-
tions were 14 (±2.7) pg/mL and 75.8 (±23.3) pg/mL (𝑃 =
0.0011) in the OA and RA group, respectively. As expected,
TNF𝛼 concentration was higher in RA than in OA synovial
fluids (9.2 (±4.5) pg/mL versus 231 (±168)) and IL-1𝛽 (1.2
(±0.37) pg/mL versus 15.8 (±6.2) pg/mL for OA and RA
patients, resp.). A positive and significant correlation was
found between GM-CSF concentration and these 2 cytokines
concentrations (𝑟 = 0.67 and 𝑟 = 0.70 with TNF𝛼 and IL-
1𝛽, resp.; 𝑃 < 0.0001). These results show that the three
main factors of monocyte viability are increased in synovial
fluids from RA patients compared to OA patients. A positive
correlation exists between IL-1𝛽 and TNF𝛼 concentrations
and GM-CSF level. Thus, in inflammatory conditions, GM-
CSF concentration is increased in the joint and can play a role
in RA patients on monocyte viability.
4. Discussion
Macrophages are key cells involved in the physiopathology of
RA. These cells are abundant in the synovial membrane and
are the main source of proinflammatory cytokines such as
TNF𝛼 or IL-1𝛽.Themechanisms leading to the accumulation
of macrophages in the synovial tissue are not entirely clear.
Using labelled autologousmonocytes,Thurlings et al. showed
that, in RA, only a small number of peripheral monocytes
migrate into the synovial compartment, indicating that
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Figure 5:MCSF, GM-CSF, TNF𝛼, and IL-1𝛽 concentrations are increased in the synovial fluid of RA patients. (a)–(d) MCSF, GM-CSF, TNF𝛼,
and IL1 concentration was assessed in synovial fluid of RA (𝑛 = 21) and OA (𝑛 = 14) patients using the Luminex technology. Each dot
represents one patient and the bar indicates the mean concentration. ∗∗𝑃 < 0.001; ∗∗∗𝑃 < 0.0001. (e)-(f) Scatter plot showing the correlation
between TNF𝛼, IL-1𝛽, and GM-CSF concentration. 𝑟 = correlation coefficient measured using the nonparametric Spearman rank order test.
the turnover of synovial macrophages from circulating
monocytes is slow [17]. Moreover, studies have shown a
decrease in macrophage apoptosis in the synovial tissue
[5]. This indicates that there is an increased viability of
macrophage precursors at the site of inflammation and
that targeting factors promoting this viability could be a
therapeutic approach in RA. In this study, we showed that RA
SF are able to promote monocyte viability and that GM-CSF,
mainly induced by IL-1𝛽 and TNF𝛼, contributes to this effect.
Synovial membrane is composed of resident cells such as
SF that are able to interact with inflammatory cells present
in the tissue. For instance, it has been shown that SF can
promote B cells viability in vitro through IL-15 expression
[18].These cells can also promoteCD4T cells and neutrophils
survival but not their proliferation [19]. Coculture of SF
with U937 cells promotes cartilage degradation through an
increase in the expression of MMPs by SF, showing that the
inflammatory cells can in turn modulate SF activity [20].
Here, we showed that SF conditioned media can promote
monocyte viability with the same efficacy as M-CSF, IL-34,
or GM-CSF. Moreover, prestimulation of the synoviocytes
for 24 hours with TNF𝛼 or IL-1𝛽 further enhances this
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effect. Interestingly, conditioned media from IL-1𝛽 stimu-
lated SF induced the maximal effect, showing a significant
increase in monocyte viability compared to M-CSF alone.
As macrophages are one of the main sources of IL-1𝛽 in the
synovial membrane, we can speculate that they might in turn
activate SF to produce factors influencing their own viability.
To identify which factors were involved in the effect of SF
onmonocytes, we next assess the expression by SF of the three
mainmonocyte survival factors (IL34,M-CSF, andGM-CSF)
and inhibit their effect using blocking antibodies. M-CSF was
the first of the hematopoietic growth factors to be isolated
[21]. It has already been shown that SF were able to produce
M-CSF, this expression being increased by dexamethasone
or retinoid and decreased by indomethacin [8, 22, 23]. It
has thus been hypothesized that M-CSF was the main SF
derived factor involved in increasing monocyte survival in
RA. However, to our knowledge, no study has given direct
proof of this effect. Here, we confirmed that M-CSF is
expressed by synoviocytes and regulated by proinflammatory
cytokines. However, we have shown that M-CSF blocking
antibodies were unable to prevent the proviability effect of
SF conditioned media. In line with this result, Dickerson
et al. recently showed that SF conditionedmedia can promote
osteoclastogenesis but the addition of M-CSF in the culture
medium was required to observe this effect [24]. Thus, if M-
CSF is expressed by SF, its biological activity needs to be
further explored.
IL-34 is a newly discovered cytokine that can substitute
for M-CSF to induce monocytes survival and osteoclasto-
genesis [25]. We were the first to demonstrate that RA SF
produce IL-34 and that this expression was increased by
TNF𝛼 stimulation [7]. Here, we showed that blocking IL-34
had no effect on monocyte viability induced by SF condi-
tioned media. Hwang et al recently studied the role of IL-34
produced by SF on osteoclastogenesis and human PBMC’s
migration [26]. They showed that addition of a blocking
antibody against IL-34 to SF conditioned media reduced the
migration of human mononuclear cells in a dose-dependent
manner. Moreover, the addition of anti-IL-34 antibodies also
significantly reduced osteoclasts formation. However, these
authors used PBMC’s as a source of osteoclasts. As IL-34 has
been shown to induce IL-17 expression by PBMC’s [27], it
remains unclear whether the observed effect is related to a
direct effect of IL-34 or to factors produced by other cells such
as lymphocytes.
In this study, we identified GM-CSF as one of the
growth factors involved in monocyte viability induced by
SF conditioned media. Interestingly, this effect was only
observed using conditioned media from IL-1𝛽 or TNF𝛼
prestimulated SF. This could be explained by the low level
of expression of GM-CSF by SF in the absence of cytokine
stimulation.We found that IL-1𝛽wasmore potent thanTNF𝛼
to induce GM-CSF production. These results are in line
with previous studies that show the importance of IL-1𝛽 in
the regulation of growth factor expression in SF [28, 29].
This effect is not limited to this type of cells and has been
described, for instance, with human lung fibroblasts. Their
production of GM-CSF is also increased in response to IL-
1𝛽 stimulation [30]. In vivo, IL-1𝛽-induced arthritis is less
severe in GM-CSF−/− mice showing that a part of IL-1𝛽
effect is mediated by GM-CSF [31]. Finally, GM-CSF effect
is not limited to the monocyte lineage as it is also able to
increase neutrophils and SF survival [32, 33]. However, even
if significant, we showed that anti-GM-CSF antibody inhibits
monocyte viability to an extent of about 30% showing that
other factors able to modulate monocyte survival are present
in the ST conditioned medium. Nevertheless, these results
confirm that GM-CSF could be an interesting target in the
treatment of RA. This is in line with the promising effect of
mavrilimumab, a monoclonal antibody targeting the alpha
subunit of the GM-CSFR, actually in clinical phase II studies
[34].
Macrophages observed in the inflamed synovial tissue of
RA patients represent a heterogeneous population composed
of both pro- and anti-inflammatory cell subtypes [35]. Their
specific polarization status might change during the course
of the disease and must be determinant in the phenotype
and severity of the disease. Moreover, high plasticity is one
of the characteristics of these cell populations. This plasticity
is regulated by the balance of pro- and anti-inflammatory
signals [36]. Ambarus et al. studied the phenotype of
macrophages by immunohistochemistry in synovial tissue of
RA and SPA patients [15]. They confirm this heterogeneity as
a majority of cells coexpressed M1 and M2 markers. Using
classical and validated markers of M1 and M2 macrophages,
we studied in vitro the effects of SF conditioned media
on macrophage polarization by FACS. Although classical
markers of M1, M2a, and M2c were induced by Interferon
gamma, IL4, and IL10, respectively, no specific markers were
upregulated in macrophages differentiated in the presence of
SF conditioned media. Conditioned media represents a mix
of different cytokines and growth factors that act at the same
time on the cells. GM-CSF differentiates macrophages in M1
phenotype [37]. On the other hand, M-CSF and IL-34 are
known to polarizemacrophages towards immunosuppressive
ones [38]. Interestingly, Foucher et al. showed that GM-CSF
prevents the generation of immunosuppressive macrophages
induced by IL-34 [39]. This shows that final polarization of
cells is the result of complex interactions between cytokines
and growth factors. If SF cannot induce a specific phenotype,
these cells could simply act to maintain the viability and
increase the half-life of immature monocytes, the polariza-
tion being the consequence of factors secreted by other cell
types present in the inflammatorymicroenvironment (B cells,
T cells, and mast cells).
Overall, SF produces factors that enhance monocyte
viability. Interestingly, in absence of TNF𝛼 or IL-1𝛽 stimula-
tion, the classical monocytes survival factors (M-CSF, GM-
CSF, or IL-34) do not appear to play a significant role in
this effect. This shows that unknown cytokines and growth
factors acting on monocytes might be involved and are still
to be discovered. Moreover, targeting one cytokine might
not be sufficient because SF conditioned media is a mix
of cytokines and growth factors that interact together to
control monocyte viability. We also showed that IL-1𝛽 is
one of the main drivers of monocyte survival through the
induction of GM-CSF production by SF. It is known that IL-
1𝛽 is one of the main cytokines involved in crystal induced
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arthritis and thatmacrophages also play a central role in these
diseases. Considering this, targeting GM-CSF could also
be promising in gout or calcium pyrophosphate deposition
disease (CPPD). Finally, if SF conditioned media did not
induce any of the classical macrophages phenotype, these
cells could promote the viability of immature monocytes
within the synovial membrane which could then be targeted
by other cytokines produced by inflammatory cells of the
microenvironment.
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